Mylan to combine with Pfizer's off patent drugs unit
30 July, 2019
Pfizer will separate its off-patent drugs business and merge it with Mylan, the two companies have confirmed, bringing blockbuster treatments Viagra, EpiPen and Lipitor under one umbrella
This deal will create a pharma group with global annual revenues worth €18bn.
For more on this story in todays Irish Times, click here